Sumatriptan does not affect arteriovenous oxygen differences in jugular and cubital veins in normal human subjects

Cephalalgia

Volumn 28, Issue 10, 2008, Pages 1081-1085

  Wienecke, T ^a   Hansen, J M ^a   Petersen, J ^a   Olsen, K S ^a   Ashina, M ^a   Tfelt Hansen, P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Arteriovenous anastomoses; Migraine; Oxygen content; Sumatriptan

Indexed keywords

SUMATRIPTAN;

ADRENERGIC SYSTEM; ADULT; ARTERIAL OXYGEN TENSION; ARTERIOVENOUS FISTULA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; JUGULAR VEIN; MALE; MIGRAINE; VENOUS OXYGEN TENSION;

ADULT; ARTERIOVENOUS ANASTOMOSIS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; JUGULAR VEINS; MALE; OXYGEN; REFERENCE VALUES; REGIONAL BLOOD FLOW; SEROTONIN AGONISTS; SUMATRIPTAN; YOUNG ADULT;

EID: 51649095719     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01602.x     Document Type: Article

References (18)

1. Heyck H. Pathogenesis of migraine. Res Clin Stud Headache 1969 2 : 1 22.
2. Heyck H. Vascular shunt mechanisms and migraine pathogenesis. Neurology 1981 31 : 1203 4.
3. Saxena P. Cranial arteriovenous shunting, an in vivo animal model for migraine. In : Olesen JMM, ed. Experimental headache models. Philadelphia, PA : Lippincott-Raven 1995 : 189 98.
4. De Vries P, Willems EW, Heiligers JP, Villalon CM, Saxena PR. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses. Br J Pharmacol 1999 127 : 405 12.
5. Spierings EL, Saxena PR. Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology 1980 30 : 696 701.
6. Saxena PR, Verdouw PD. Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol 1984 82 : 817 26.
7. Saxena PR. Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol 1974 27 : 99 105.
8. Humphrey PP. The discovery of a new drug class for the acute treatment of migraine. Headache 2007 47 (Suppl. 1 S10 19.
9. Sherman JL Jr. Normal arteriovenous anastomoses. Medicine (Baltimore) 1963 42 : 247 67.
10. Kerber CW, Newton TH. The macro and microvasculature of the dura mater. Neuroradiology 1973 6 : 175 9.
11. Midttun M, Sejrsen P. Blood flow rate in arteriovenous anastomoses and capillaries in thumb, first toe, ear lobe, and nose. Clin Physiol 1996 16 : 275 89.
12. van Es NM, Bruning TA, Camps J, Chang PC, Blauw GJ, Ferrari MD et al. Assessment of peripheral vascular effects of antimigraine drugs in humans. Cephalalgia 1995 15 : 288 91.
13. Lacey LF, Hussey EK, Fowler PA. Single dose pharmacokinetics of sumatriptan in healthy volunteers. Eur J Clin Pharmacol 1995 47 : 543 8.
14. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991 338 : 13 17.
15. Arulmani U, Gupta S, VanDenBrink AM, Centurion D, Villalon CM, Saxena PR. Experimental migraine models and their relevance in migraine therapy. Cephalalgia 2006 26 : 642 59.
16. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000 60 : 1259 87.
17. Feniuk W, Humphrey PP, Perren MJ. The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol 1989 96 : 83 90.
18. Den Boer MO, Van Woerkens LJ, Somers JA, Duncker DJ, Lachmann B, Saxena PR et al. On the preservation and regulation of vascular tone in arteriovenous anastomoses during anesthesia. J Appl Physiol 1993 75 : 782 9.